Florian Rosar

1.4k total citations
76 papers, 1.0k citations indexed

About

Florian Rosar is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Florian Rosar has authored 76 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 57 papers in Radiology, Nuclear Medicine and Imaging and 27 papers in Oncology. Recurrent topics in Florian Rosar's work include Radiopharmaceutical Chemistry and Applications (57 papers), Prostate Cancer Treatment and Research (53 papers) and Peptidase Inhibition and Analysis (22 papers). Florian Rosar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (57 papers), Prostate Cancer Treatment and Research (53 papers) and Peptidase Inhibition and Analysis (22 papers). Florian Rosar collaborates with scholars based in Germany, Switzerland and United States. Florian Rosar's co-authors include Samer Ezziddin, Fadi Khreish, Mark Bartholomä, Stephan Maus, Tobias Stemler, Johannes Linxweiler, Mathias Schreckenberger, Martin Ries, Manuela A. Hoffmann and Caroline Burgard and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Florian Rosar

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Rosar Germany 21 823 804 290 100 65 76 1.0k
Fadi Khreish Germany 17 710 0.9× 686 0.9× 270 0.9× 84 0.8× 59 0.9× 46 867
Karina Knorr Germany 12 819 1.0× 851 1.1× 290 1.0× 103 1.0× 69 1.1× 29 1.0k
Stephan Maus Germany 20 851 1.0× 719 0.9× 284 1.0× 64 0.6× 71 1.1× 67 1.1k
Martina Weineisen Germany 7 742 0.9× 754 0.9× 250 0.9× 52 0.5× 79 1.2× 12 942
Thomas Langbein Germany 14 498 0.6× 445 0.6× 209 0.7× 50 0.5× 43 0.7× 37 775
Mark Scalzo Australia 7 1.1k 1.3× 1.1k 1.3× 398 1.4× 117 1.2× 110 1.7× 10 1.3k
Stefan Kürpig Germany 15 1.2k 1.4× 1.0k 1.3× 461 1.6× 88 0.9× 97 1.5× 25 1.3k
Srinivasan Senthamizhchelvan United States 14 820 1.0× 581 0.7× 160 0.6× 113 1.1× 83 1.3× 26 1.1k
Martina Wirtz Germany 8 535 0.7× 560 0.7× 207 0.7× 39 0.4× 58 0.9× 8 683
Andrei Gafita United States 23 1.5k 1.8× 1.6k 1.9× 373 1.3× 209 2.1× 105 1.6× 93 1.9k

Countries citing papers authored by Florian Rosar

Since Specialization
Citations

This map shows the geographic impact of Florian Rosar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Rosar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Rosar more than expected).

Fields of papers citing papers by Florian Rosar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Rosar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Rosar. The network helps show where Florian Rosar may publish in the future.

Co-authorship network of co-authors of Florian Rosar

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Rosar. A scholar is included among the top collaborators of Florian Rosar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Rosar. Florian Rosar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgard, Caroline, Florian Rosar, Samer Ezziddin, et al.. (2025). [68Ga]Ga-FAPI-04 PET/CT in a patient with endometriosis: a potential game changer?. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4350–4351.
2.
Berger, Fabian K., Walter Schulz‐Schaeffer, Klaus Faßbender, et al.. (2025). Severe coxsackie virus B5 encephalitis mimics autoimmune limbic encephalitis in a young woman under long-term B-cell depletion with ocrelizumab: A case report. Multiple Sclerosis Journal. 31(10). 1258–1261.
3.
Maus, Stephan, et al.. (2025). Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+. Nuclear Medicine and Biology. 146-147. 109034–109034. 3 indexed citations
4.
Christofyllakis, Konstantinos, et al.. (2025). [18F]FDG PET/CT of Langerhans Cell Histiocytosis with Vertebra Plana. Diagnostics. 15(7). 862–862.
5.
Burgard, Caroline, Mark Bartholomä, Stephan Maus, et al.. (2025). Tumor sink effect in PSMA-targeted theranostics: intra-patient evaluation of a cohort receiving 225Ac/177Lu-PSMA tandem radioligand therapy. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 69(2). 137–145.
6.
7.
Schaefer-Schuler, Andrea, Caroline Burgard, Stephan Maus, et al.. (2024). [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617. Theranostics. 14(5). 1829–1840. 22 indexed citations
8.
Rosar, Florian, Caroline Burgard, Mark Bartholomä, et al.. (2024). 225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Clinical Nuclear Medicine. 49(7). 621–629. 5 indexed citations
9.
10.
Rosar, Florian, Caroline Burgard, Robert J. Marlowe, et al.. (2024). Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific Reports. 14(1). 11271–11271. 6 indexed citations
11.
Stemler, Tobias, Florian Rosar, Caroline Burgard, et al.. (2024). Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform. EJNMMI Radiopharmacy and Chemistry. 9(1). 84–84. 2 indexed citations
12.
13.
Burgard, Caroline, Mark Bartholomä, Stephan Maus, et al.. (2024). Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function. Clinical Nuclear Medicine. 50(2). 165–171.
14.
Burgard, Caroline, et al.. (2024). Diffuse Peritoneal Carcinomatosis of Prostate Cancer Unveiled by [89Zr]Zr-PSMA-617 PET/CT. Clinical Nuclear Medicine. 50(2). 191–192.
15.
Rosar, Florian, Caroline Burgard, Johannes Linxweiler, Mathias Wagner, & Samer Ezziddin. (2023). Histologically Confirmed Testicular Metastasis Revealed by [89Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging. Diagnostics. 13(7). 1352–1352. 2 indexed citations
16.
Rosar, Florian, Fadi Khreish, Robert J. Marlowe, et al.. (2023). Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2899–2909. 13 indexed citations
17.
Burgard, Caroline, Tobias Stemler, Stephan Maus, et al.. (2023). Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. Molecular Pharmaceutics. 20(12). 6463–6473. 1 indexed citations
18.
Maus, Stephan, Florian Rosar, Juri Ruf, et al.. (2021). Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617. Journal of Medicinal Chemistry. 64(8). 4960–4971. 18 indexed citations
19.
Maus, Stephan, Tobias Stemler, Florian Rosar, et al.. (2020). Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular Imaging and Biology. 23(1). 95–108. 7 indexed citations
20.
Rosar, Florian, Martin Ries, Fadi Khreish, & Samer Ezziddin. (2019). Remember the Pitfall. Clinical Nuclear Medicine. 45(3). 250–251. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fadi Khreish Breakdown of academic impact, for papers by Karina Knorr Breakdown of academic impact, for papers by Stephan Maus Breakdown of academic impact, for papers by Martina Weineisen Breakdown of academic impact, for papers by Thomas Langbein Breakdown of academic impact, for papers by Mark Scalzo Breakdown of academic impact, for papers by Stefan Kürpig Breakdown of academic impact, for papers by Srinivasan Senthamizhchelvan Breakdown of academic impact, for papers by Martina Wirtz Breakdown of academic impact, for papers by Andrei Gafita
Rankless by CCL
2026